1
|
Croxton T, Jonathan E, Suleiman K, Balogun O, Ozumba PJ, Aloyo SM, Nsubuga G, Kamulegeya RE, Newton L, Mukisa J, Kader M, Damaneite V, Nadoma S, Onyemata EJ, Anzaku AA, Nasinghe E, Troyer J, Joubert BR, Beiswanger C, Joloba ML, Mayne E, Abimiku A. Building blocks for better biorepositories in Africa. Genome Med 2023; 15:92. [PMID: 37932809 PMCID: PMC10626646 DOI: 10.1186/s13073-023-01235-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/30/2023] [Accepted: 09/19/2023] [Indexed: 11/08/2023] Open
Abstract
BACKGROUND Biorepositories archive and distribute well-characterized biospecimens for research to support the development of medical diagnostics and therapeutics. Knowledge of biobanking and associated practices is incomplete in low- and middle-income countries where disease burden is disproportionately high. In 2011, the African Society of Human Genetics (AfSHG), the National Institutes of Health (NIH), and the Wellcome Trust founded the Human Heredity and Health in Africa (H3Africa) consortium to promote genomic research in Africa and established a network of three biorepositories regionally located in East, West, and Southern Africa to support biomedical research. This manuscript describes the processes established by H3Africa biorepositories to prepare research sites to collect high-quality biospecimens for deposit at H3Africa biorepositories. METHODS The biorepositories harmonized practices between the biorepositories and the research sites. The biorepositories developed guidelines to establish best practices and define biospecimen requirements; standard operating procedures (SOPs) for common processes such as biospecimen collection, processing, storage, transportation, and documentation as references; requirements for minimal associated datasets and formats; and a template material transfer agreements (MTA) to govern biospecimen exchange. The biorepositories also trained and mentored collection sites in relevant biobanking processes and procedures and verified biospecimen deposit processes. Throughout these procedures, the biorepositories followed ethical and legal requirements. RESULTS The 20 research projects deposited 107,982 biospecimens (76% DNA, 81,067), in accordance with the ethical and legal requirements and established best practices. The biorepositories developed and customized resources and human capacity building to support the projects. [The biorepositories developed 34 guidelines, SOPs, and documents; trained 176 clinicians and scientists in over 30 topics; sensitized ethical bodies; established MTAs and reviewed consent forms for all projects; attained import permits; and evaluated pilot exercises and provided feedback. CONCLUSIONS Biobanking in low- and middle-income countries by local skilled staff is critical to advance biobanking and genomic research and requires human capacity and resources for global partnerships. Biorepositories can help build human capacity and resources to support biobanking by partnering with researchers. Partnerships can be structured and customized to incorporate document development, ethics, training, mentorship, and pilots to prepare sites to collect, process, store, and transport biospecimens of high quality for future research.
Collapse
Affiliation(s)
- Talishiea Croxton
- I-HAB, Institute of Human Virology Nigeria, Abuja, Nigeria.
- University of Maryland School of Medicine, Institute of Human Virology, University of Maryland Baltimore, 725 West Lombard Street Suite, Baltimore, MD, USA.
| | | | | | | | | | - Sharley M Aloyo
- Integrated Biorepository of H3Africa Uganda, Kampala, Uganda
- Makerere University, Kampala, Uganda
| | - Gideon Nsubuga
- Integrated Biorepository of H3Africa Uganda, Kampala, Uganda
- Makerere University, Kampala, Uganda
| | - Rogers E Kamulegeya
- Integrated Biorepository of H3Africa Uganda, Kampala, Uganda
- Makerere University, Kampala, Uganda
| | - Lwanga Newton
- Integrated Biorepository of H3Africa Uganda, Kampala, Uganda
- Makerere University, Kampala, Uganda
| | - John Mukisa
- Integrated Biorepository of H3Africa Uganda, Kampala, Uganda
- Makerere University, Kampala, Uganda
| | - Mukthar Kader
- Clinical Laboratory Services, Wits Diagnostic Innovation Hub, University of the Witwatersrand, Johannesburg, South Africa
| | - Vuyo Damaneite
- Clinical Laboratory Services, Wits Diagnostic Innovation Hub, University of the Witwatersrand, Johannesburg, South Africa
| | - Sunji Nadoma
- I-HAB, Institute of Human Virology Nigeria, Abuja, Nigeria
| | | | | | - Emmanuel Nasinghe
- Integrated Biorepository of H3Africa Uganda, Kampala, Uganda
- Makerere University, Kampala, Uganda
| | - Jennifer Troyer
- National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA
| | - Bonnie R Joubert
- National Institute of Environmental Health Sciences, National Institutes of Health, Durham, NC, USA
| | - Christine Beiswanger
- University of Maryland School of Medicine, Institute of Human Virology, University of Maryland Baltimore, 725 West Lombard Street Suite, Baltimore, MD, USA
| | - Moses L Joloba
- Integrated Biorepository of H3Africa Uganda, Kampala, Uganda
- Makerere University, Kampala, Uganda
| | - Elizabeth Mayne
- Division of Immunology, Department of Pathology, Faculty of Health Sciences, University of Cape Town, National Health Laboratory Service, Johannesburg, South Africa
| | - Alash'le Abimiku
- I-HAB, Institute of Human Virology Nigeria, Abuja, Nigeria
- University of Maryland School of Medicine, Institute of Human Virology, University of Maryland Baltimore, 725 West Lombard Street Suite, Baltimore, MD, USA
| |
Collapse
|
2
|
Onyemata EJ, Jonathan E, Balogun O, Agala N, Ozumba PJ, Croxton T, Nadoma S, Anazodo T, Peters S, Beiswanger CM, Abimiku A. Affordable method for quality DNA for genomic research in low to middle-income country research settings. Anal Biochem 2020; 614:114023. [PMID: 33249001 DOI: 10.1016/j.ab.2020.114023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2020] [Revised: 10/27/2020] [Accepted: 11/16/2020] [Indexed: 10/22/2022]
Affiliation(s)
- Ezenwa James Onyemata
- International Research Center of Excellence Institute of Human Virology Nigeria Plot 252 Herbert Macaulay Way Central Business District, Abuja, 900211, Nigeria.
| | - Emmanuel Jonathan
- International Research Center of Excellence Institute of Human Virology Nigeria Plot 252 Herbert Macaulay Way Central Business District, Abuja, 900211, Nigeria.
| | - Olasinbo Balogun
- International Research Center of Excellence Institute of Human Virology Nigeria Plot 252 Herbert Macaulay Way Central Business District, Abuja, 900211, Nigeria.
| | - Ndidi Agala
- International Research Center of Excellence Institute of Human Virology Nigeria Plot 252 Herbert Macaulay Way Central Business District, Abuja, 900211, Nigeria.
| | - Petronilla Jean Ozumba
- International Research Center of Excellence Institute of Human Virology Nigeria Plot 252 Herbert Macaulay Way Central Business District, Abuja, 900211, Nigeria.
| | - Talishiea Croxton
- International Research Center of Excellence Institute of Human Virology Nigeria Plot 252 Herbert Macaulay Way Central Business District, Abuja, 900211, Nigeria; Institute of Human Virology at the University of Maryland School of Medicine Baltimore MD, 21201, USA.
| | - Sunji Nadoma
- International Research Center of Excellence Institute of Human Virology Nigeria Plot 252 Herbert Macaulay Way Central Business District, Abuja, 900211, Nigeria.
| | - ThankGod Anazodo
- International Research Center of Excellence Institute of Human Virology Nigeria Plot 252 Herbert Macaulay Way Central Business District, Abuja, 900211, Nigeria.
| | - Sam Peters
- International Research Center of Excellence Institute of Human Virology Nigeria Plot 252 Herbert Macaulay Way Central Business District, Abuja, 900211, Nigeria.
| | | | - Alash'le Abimiku
- International Research Center of Excellence Institute of Human Virology Nigeria Plot 252 Herbert Macaulay Way Central Business District, Abuja, 900211, Nigeria; Institute of Human Virology at the University of Maryland School of Medicine Baltimore MD, 21201, USA.
| |
Collapse
|
3
|
Croxton T, Agala N, Jonathan E, Balogun O, Ozumba PJ, Onyemata E, Lawal S, Mamven M, Ajayi S, Melikam SE, Owolabi M, Ovbiagele B, Adu D, Ojo A, Beiswanger CM, Abimiku A. H3Africa partnerships to empower clinical research sites to generate high-quality biological samples. Afr J Lab Med 2020; 9:935. [PMID: 32284923 PMCID: PMC7136697 DOI: 10.4102/ajlm.v9i1.935] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2018] [Accepted: 12/12/2019] [Indexed: 11/23/2022] Open
Abstract
Background The Institute of Human Virology Nigeria (IHVN) – Human Heredity and Health in Africa (H3Africa) Biorepository (I-HAB) seeks to provide high-quality biospecimens for research. This depends on the ability of clinical research sites (CRS) – who provide biospecimens – to operate according to well-established industry standards. Yet, standards are often neglected at CRSs located in Africa. Here, I-HAB reports on its four-pronged approach to empower CRSs to prepare high-quality biospecimens for research. Objectives I-HAB sought (1) to assess a four-pronged approach to improve biobanking practices and sample quality among CRSs, and (2) to build human capacity. Methods I-HAB partnered with two H3Africa principal investigators located in Nigeria and Ghana from August 2013 through to May 2017 to debut its four-pronged approach (needs assessment, training and mentorship, pilot, and continuous quality improvement) to empower CRSs to attain high-quality biospecimens. Results Close collaborations were instrumental in establishing mutually beneficial and lasting relationships. Improvements during the 12 months of engagement with CRSs involved personnel, procedural, and supply upgrades. In total, 51 staff were trained in over 20 topics. During the pilot, CRSs extracted 50 DNA biospecimens from whole blood and performed quality control. The CRSs shipped extracted DNA to I-HAB and I-HAB that comparatively analysed the DNA. Remediation was achieved via recommendations, training, and mentorship. Preanalytical, analytical and post-analytical processes, standard operating procedures, and workflows were systematically developed. Conclusion Partnerships between I-HAB and H3Africa CRSs enabled research sites to produce high-quality biospecimens through needs assessment, training and mentorship, pilot, and continuous monitoring and improvement.
Collapse
Affiliation(s)
- Talishiea Croxton
- Institute of Human Virology Nigeria, Abuja, Nigeria.,Institute of Human Virology, University of Maryland, Baltimore, Maryland, United States
| | - Ndidi Agala
- Institute of Human Virology Nigeria, Abuja, Nigeria
| | | | | | | | | | - Shefiya Lawal
- Department of Internal Medicine, University of Abuja Teaching Hospital, Abuja, Nigeria
| | - Manmak Mamven
- Department of Internal Medicine, University of Abuja Teaching Hospital, Abuja, Nigeria
| | - Samuel Ajayi
- Department of Medicine, University of Abuja Teaching Hospital, Abuja, Nigeria
| | | | - Mayowa Owolabi
- Center for Genomic and Precision Medicine, College of Medicine, University of Ibadan, Ibadan, Nigeria
| | - Bruce Ovbiagele
- Department of Neurology, University of Ghana Medical School, Accra, Ghana
| | - Dwomoa Adu
- Department of Neurology, Medical University of South Carolina, Charleston, South Carolina, United States
| | - Akinlolu Ojo
- Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, United States
| | - Christine M Beiswanger
- Coriell Institute for Medical Research, Camden, New Jersey.,Independent Contractor, Philadelphia, Pennsylvania, United States
| | - Alash'le Abimiku
- Institute of Human Virology Nigeria, Abuja, Nigeria.,Institute of Human Virology, University of Maryland, Baltimore, Maryland, United States
| |
Collapse
|
4
|
Abimiku AG, Croxton T, Ozumba PJ, Agala N, Balogun O, Jonathan E, Onyemata E, Ndifon K, Nadoma S, Anazodo T, Peters S, Beiswanger CM. Blueprint for building a biorepository in a resource-limited setting that follows international best practices. Afr J Lab Med 2019; 8:722. [PMID: 31534913 PMCID: PMC6739520 DOI: 10.4102/ajlm.v8i1.722] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2017] [Accepted: 03/22/2019] [Indexed: 12/16/2022] Open
Abstract
BACKGROUND Genetic diversity is abundant on the African continent. However, genomic research has been hampered by a lack of high quality and extensively annotated biospecimens and the necessary infrastructure to support such a technology-intensive effort. OBJECTIVE The Institute of Human Virology Nigeria (IHVN) partnered with the H3Africa Consortium and the Coriell Institute for Medical Research to build an internationally recognised biorepository for the receipt, processing, storage and distribution of biospecimens for biomedical research. Here, the authors describe the procedures, challenges and results encountered. RESULTS Key requirements for a high-quality biorepository were identified: (1) institutional support of infrastructure and services, (2) on-site trained staff with primary commitment to the biorepository, (3) reliance on best practices from globally recognised biorepository groups, (4) early implementation of a quality management system, (5) adoption of a laboratory information management system with demonstrated versatility in functions, (6) collaboration with external experts and sharing of experience through abstracts, newsletters, published manuscripts, and attendance at meetings and workshops, (7) strict adherence to local and national ethical standards and (8) a sustainability plan that is reviewed and updated annually. CONCLUSION Utilising published best practices of globally recognised experts in the biorepository field as a benchmark, IHVN expanded and reorganised its existing laboratory facility and staff to take on this new purpose.
Collapse
Affiliation(s)
- Alash'le G Abimiku
- Institute of Human Virology Nigeria, Abuja, Nigeria
- Institute of Human Virology, University of Maryland, Baltimore, Maryland, United States
| | - Talishea Croxton
- Institute of Human Virology Nigeria, Abuja, Nigeria
- Institute of Human Virology, University of Maryland, Baltimore, Maryland, United States
| | | | - Ndidi Agala
- Institute of Human Virology Nigeria, Abuja, Nigeria
| | | | | | | | | | - Sunji Nadoma
- Institute of Human Virology Nigeria, Abuja, Nigeria
| | | | - Sam Peters
- Institute of Human Virology Nigeria, Abuja, Nigeria
| | - Christine M Beiswanger
- Coriell Institute for Medical Research, Camden, New Jersey, United States
- Independent contractor, Philadelphia, Pennsylvania, United States
| |
Collapse
|
5
|
Croxton T, Swanepoel C, Musinguzi H, Kader M, Ozumba P, Pillay AD, Syed R, Swartz G, Kyobe S, Lwanga N, Katabazi FA, Edgar K, Ndidi A, Jonathan E, Onyemata E, Isaacs S, Mayne ES, Joloba M, Jentsch U, Abayomi A, Abimiku A, Troyer J, Penno S, H3Africa Biorepository PI Committee. Lessons Learned from Biospecimen Shipping Among the Human Heredity and Health in Africa Biorepositories. Biopreserv Biobank 2017. [DOI: 10.1089/bio.2017.0009] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022] Open
Affiliation(s)
- Talishiea Croxton
- Clinical Laboratory Department, Institute of Human Virology-Nigeria, Abuja, Nigeria
- Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland
| | - Carmen Swanepoel
- Division of Haematology, National Health Laboratory Services (NHLS), Tygerberg Hospital, Cape Town, South Africa
- Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, South Africa
| | - Henry Musinguzi
- Department of Medical Microbiology, Makerere University College of Health Sciences, Kampala, Uganda
| | - Mukthar Kader
- Clinical Laboratory Services-Wits Health Consortium, Johannesburg, South Africa
| | - Petronilla Ozumba
- Clinical Laboratory Department, Institute of Human Virology-Nigeria, Abuja, Nigeria
| | - Azure-Dee Pillay
- Clinical Laboratory Services-Wits Health Consortium, Johannesburg, South Africa
| | - Raeesa Syed
- Clinical Laboratory Services-Wits Health Consortium, Johannesburg, South Africa
| | - Garth Swartz
- Clinical Laboratory Services-Wits Health Consortium, Johannesburg, South Africa
| | - Samuel Kyobe
- Department of Medical Microbiology, Makerere University College of Health Sciences, Kampala, Uganda
| | - Newton Lwanga
- Department of Medical Microbiology, Makerere University College of Health Sciences, Kampala, Uganda
| | - Fred Ashaba Katabazi
- Department of Medical Microbiology, Makerere University College of Health Sciences, Kampala, Uganda
| | - Kigozi Edgar
- Department of Medical Microbiology, Makerere University College of Health Sciences, Kampala, Uganda
| | - Agala Ndidi
- Clinical Laboratory Department, Institute of Human Virology-Nigeria, Abuja, Nigeria
| | - Emmanuel Jonathan
- Clinical Laboratory Department, Institute of Human Virology-Nigeria, Abuja, Nigeria
| | - Enzenwa Onyemata
- Clinical Laboratory Department, Institute of Human Virology-Nigeria, Abuja, Nigeria
| | - Shafieka Isaacs
- Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, South Africa
| | | | - Moses Joloba
- Department of Medical Microbiology, Makerere University College of Health Sciences, Kampala, Uganda
| | - Ute Jentsch
- Clinical Laboratory Services-Wits Health Consortium, Johannesburg, South Africa
| | - Akin Abayomi
- Division of Haematology, National Health Laboratory Services (NHLS), Tygerberg Hospital, Cape Town, South Africa
- Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, South Africa
| | - Alash'le Abimiku
- Clinical Laboratory Department, Institute of Human Virology-Nigeria, Abuja, Nigeria
- Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland
| | - Jennifer Troyer
- National Human Genome Research Institute, National Institutes of Health and Human Services, Bethesda, Maryland
| | - Sue Penno
- National Human Genome Research Institute, National Institutes of Health and Human Services, Bethesda, Maryland
| | | |
Collapse
|
6
|
Advani R, Horning SJ, Jonathan E, Daadi S, Allen J, Rosenberg SA, Hoppe RT. Abbreviated 8-week chemotherapy (CT) plus involved node radiotherapy (INRT) for nonbulky stage I-II Hodgkin lymphoma: Preliminary results of the Stanford G5 Study. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.8064] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
7
|
Abstract
Current-generation smartphones boast a video unit comprising a camera next to a white light emitting diode and this configuration would be suitable for reflection-mode bio-optical sensing and imaging applications. We demonstrate reflection photoplethysmographic (PPG) imaging using this technology on the index finger of a male volunteer during rest and immediately after performing a short run. The returned signals carry useful PPG signals and were used, for example, to compute change in heart rate. Our results are encouraging, especially in the area of personal and home-based care applications.
Collapse
Affiliation(s)
- E Jonathan
- Tissue Optics and Microcirculation Imaging Facility, National Biophotonics and Imaging Platform Ireland, UK.
| | | |
Collapse
|